Endicott David J. 4
4 · ALLERGAN INC · Filed Feb 22, 2013
Insider Transaction Report
Form 4
ALLERGAN INCAGN
Endicott David J.
CVP and President, AGN Med US
Transactions
- Tax Payment
Common Stock
2013-02-20$108.08/sh−2,794$301,976→ 17,335 total - Award
Employee Stock Option (Right to Buy)
2013-02-21+40,000→ 40,000 totalExercise: $105.87Exp: 2023-02-21→ Common Stock (40,000 underlying)
Holdings
- 3,113.565(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Exempt disposition to the issuer, effective 2/20/2013, transaction date, of a number of shares determined to be sufficient to satisfy tax withholding obligations resulting from the lapse of restrictions of an exempt award of 7,000 shares of restricted stock granted on 2/20/2009.
- [F2]Shares allocated to the reporting person's ESOP account as of reporting date.
- [F3]The option becomes exercisable in four equal annual installments beginning February 21, 2014.